Skip to content
Saturday 12 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,650.44
+0.39%
DAX
25,568.56
+0.82%
CAC 40
8,179.77
+0.78%
STOXX 50
6,325.13
+0.90%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Sponsored Ad Feature is produced by an advertiser with the specific intent to promote a product and is not produced by the Morning Wire team.
Tuesday 29 December 2020 9:00 am  |  Updated:  Friday 18 December 2020 10:59 am

How advanced cell therapy can help you

By:

Add as a preferred source on Google

Picture a world where individually personalised medicine is available to anyone.

LifePlus Stem Cells is the first stem cell service in the UK to provide doctors and prescribers with quantifiable, quality-assured autologous and allogeneic stem cells to be prescribed for a wide range of medical conditions. 

Adipose-derived stem cell treatments are multiplied to more than 20 times their original concentration with analysis on potency, purity and sterility. All products are put through stringent regulation and testing at every step of the process. All products are manufactured under strict UK and EU regulations. 

Every prescriber receives a certificate of analysis that certifies the quantity, potency, sterility and quality of stem cells harvested for their treatments. lifeplusstemcells.com

Read more

ReNew Reports 25.6% Reduction in Scope 1 & 2 Emissions and 24.7 Billion Units of Clean Power Generated in FY 2025-26

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Categories

  • Life&Style

Trending Articles

  • Serie A won’t catch the Premier League by selling its rights better

  • Last Night, a Star-studded Evening Celebrating Moncler’s Fifth Avenue Flagship Ushered in a New Chapter in the Brand’s Enduring Love Story With New York

  • Crystal Palace agree deal with HSBC that paves way for new training ground

  • Lotus, Porsche and Corvette: the best sports cars to buy in 2026

  • Claridge’s swings to £10m loss as luxury hotel warns on ‘adverse impact’ of tax hikes

More from Morning Wire

  • ReNew Reports 25.6% Reduction in Scope 1 & 2 Emissions and 24.7 Billion Units of Clean Power Generated in FY 2025-26

    Business Wire
  • UK economy’s rebound fails to stem two years of mass job losses 

    Economics
    LONDON, UNITED KINGDOM - JANUARY 31: The Shard is seen on the horizon as commuters cross London Bridge during the morning rush hour on January 31, 2023 in London, United Kingdom. The IMF reports that the UK economy will contract by 0.6% in 2023, as opposed to the previous prediction it might grow, and will perform worse than many other advanced economies, including Russia.The cost of living continues to hit households with grocery inflation for the first four weeks of 2023 rising to 16.7% which would add a further £788 per year to family food bills. (Photo by Leon Neal/Getty Images)
  • IMU Biosciences and Eurofins Transplant Genomics Form Strategic Partnership to Advance Transplant-Related Clinical Development Programmes

    Business Wire
  • ReNew Announces Results for the First Quarter for Fiscal Year 2027 (Q1 FY27), Ended June 30, 2026

    Business Wire
  • ‘Hard work ahead’: Diageo shares soar as Drastic Dave’s cost savings lift investor spirits

    Markets
    Diageo is expected to reveal a drop in profits for the past year
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • Could a ‘land blocking’ rule change spell danger for Aldi and Lidl?

    Retail
    Lidl supermarket sign with blue, yellow, and red logo against a clear blue sky
  • Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook